NCT03017183View on ClinicalTrials.gov

Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Lung Neoplasms
Interventions
PROCEDURE

EBUS-TBNA

Endobronchial ultrasound guided transbronchial needle aspiration

PROCEDURE

Endobronchial forceps biopsy

Conventional endobronchial forceps biopsy

Trial Locations (1)

42699

Krankenhaus Bethanien gGmbH, Solingen

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

lead

Wissenschaftliches Institut Bethanien e.V

OTHER